Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Michael J Fox Foundation for Parkinson's Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9340
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Michael J Fox Foundation for Parkinson’s Research (Michael J. Fox) is a research foundation that conducts research on Parkinson’s disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments which include deep brain stimulation, medication and therapy development. The foundation operates through drug development service companies, pharmaceuticals and healthcare centers. It collaborates with other companies to enhance its research programs through funding, in-kind contributions, strategic input, and others. Michael J. Fox is headquartered in New York, the US.

Michael J Fox Foundation for Parkinson’s Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson’s Research, Medical Devices Deals, 2012 to YTD 2018 9
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
MJFF Acquires Research Tools from Imago Pharma 11
Partnerships 12
ViGene Enters into Agreement with Michael J. Fox 12
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson’s Trust 13
Charles River Labs Expands Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
Merger 18
Michael J. Fox Foundation and Michael Stern Parkinson’s Research Foundation Merge 18
Michael J Fox Foundation for Parkinson’s Research – Key Competitors 19
Michael J Fox Foundation for Parkinson’s Research – Key Employees 20
Michael J Fox Foundation for Parkinson’s Research – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Apr 19, 2017: The Michael J. Fox Foundation Promotes Sohini Chowdhury to Deputy Chief Executive Officer 23
Government and Public Interest 24
Apr 11, 2018: Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation 24
Oct 03, 2017: AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinsons Research 25
May 20, 2017: Wim Versees receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Key Facts 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson's Research, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson's Research, Medical Devices Deals, 2012 to YTD 2018 9
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MJFF Acquires Research Tools from Imago Pharma 11
ViGene Enters into Agreement with Michael J. Fox 12
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson's Trust 13
Charles River Labs Expands Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
Michael J. Fox Foundation and Michael Stern Parkinson's Research Foundation Merge 18
Michael J Fox Foundation for Parkinson's Research, Key Competitors 19
Michael J Fox Foundation for Parkinson's Research, Key Employees 20

List of Figures
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson's Research, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Defence Research and Development Organisation:企業の戦略・SWOT・財務情報
    Defence Research and Development Organisation - Strategy, SWOT and Corporate Finance Report Summary Defence Research and Development Organisation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Rothschild Bank AG:企業の戦略・SWOT・財務情報
    Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report Summary Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Janssen Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Janssen Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Central Electricity Generating Co:企業の発電所・SWOT分析2018
    Central Electricity Generating Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • China Eastern Airlines Corporation Limited
    China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Empyrean Energy PLC (EME):企業の財務・戦略的SWOT分析
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company's projects include China Block 29/11 project, Duyung PSC project, and Sacramento Basin Projects. Its Duyung PSC project covers a …
  • Invuity Inc (IVTY)-医療機器分野:企業M&A・提携分析
    Summary Invuity Inc (Invuity) is a medical technology company that offers visualization products for the less invasive surgical procedures. The company offers handhelds, retractors and drop-ins. Its handhelds products include saber frazier and saber yankauer. Invuity offers retractors such as breite …
  • Centrais Eletricas Brasileiras S.A. (ELET6):電力:M&Aディール及び事業提携情報
    Summary Centrais Eletricas Brasileiras S.A. (Eletrobras) is an electric utility. It generates, transmits, and distributes energy. The company produces electricity from hydro, nuclear, wind, natural gas, oil, coal, solar, and biomass sources. Eletrobras promotes the Latin American electric integratio …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • Pioneer Corporation:企業の戦略・SWOT・財務情報
    Pioneer Corporation - Strategy, SWOT and Corporate Finance Report Summary Pioneer Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CorMedix Inc (CRMD):製薬・医療:M&Aディール及び事業提携情報
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • CJ ENM Co., Ltd. (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co., Ltd. (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Artizian Catering Services Ltd:企業の戦略・SWOT・財務分析
    Artizian Catering Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Artizian Catering Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mitsui O.S.K. Lines Ltd (9104):企業の財務・戦略的SWOT分析
    Mitsui O.S.K. Lines Ltd (9104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Calimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Calimmune Inc (Calimmune), a subsidiary of CSL Behring Australia Pty Ltd, is a novel gene therapy program developer. The company’s ex vivio autulogus cell therapy includes CAL-1 and CAL-H. Its CAL-1 offers cell therapies for HIV AIDS. Calimmune’s CAL-H cell therapy provides himoglobinopathie …
  • Sumitomo Corporation (8053):企業の財務・戦略的SWOT分析
    Sumitomo Corporation (8053) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, in …
  • Punch Taverns Plc:企業のM&A・事業提携・投資動向
    Punch Taverns Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Punch Taverns Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆